Heron Therapeutics | HRTX - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
ALKERMES USD 1.75B 67.76M 2026-03
Alnylam Pharmaceuticals USD 1.08B 286.2M 2026-03
Amarin USD 449.41M 9.87M 2026-03
ANI Pharmaceuticals USD 562.3M 21.58M 2026-03
Anika Therapeutics USD 133.9M 9.56M 2026-03
Arrowhead Research USD 613.98M 45.56M 2026-03
Eisai JPY 898.99B 9.36B 2026-03
Emergent BioSolutions USD 649.3M 47.9M 2023-12
Esperion Therapeutics USD -307.93M 5.97M 2026-03
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Heron Therapeutics USD 9.14M 4.15M 2026-03
Insmed USD 704.85M 34.12M 2026-03
Ligand Pharmaceuticals USD 997.32M 19.89M 2026-03
Merck USD 45.88B 6.73B 2026-03
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Neurocrine Biosciences USD 3.41B 154.3M 2026-03
Omeros USD -228.68M 15.13M 2025-06
Pacira USD 653.89M 39.22M 2026-03
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Ultragenyx Pharmaceutical USD -236M 156M 2026-03
Veracyte USD 1.34B 34.83M 2026-03
Vertex Pharmaceuticals USD 19.36B 696.1M 2026-03